Back to search

Sweden· SE-19670122000011

Celeston bifas 5,7 mg/ml Injektionsvätska, suspension

A medicinal product containing betamethasone acetate + betamethasone sodium phosphate, registered in Sweden by NV Organon.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedCeleston bifas 5,7 mg/ml Injektionsvä…ATC—REGISTER NO.SE-19670122000011PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Betamethasone Acetate + Betamethasone Sodium Phosphate
Manufacturer
NV Organon
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    19670122000011

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Betamethasone acetate + betamethasone sodium phosphate in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All betamethasone acetate + betamethasone sodium phosphate products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Celestan Biphase, Diprophos
  • Belgium · Celestone Chronodose, Diprophos Ampoule
  • Bulgaria · Дипрофос
  • Germany · Celestan Depot, Diprosone Depot 1 Ml Ampulle
  • Denmark · Diprospan
  • Spain · Celestone Cronodose
  • Finland · Celeston Chronodose
  • France · Celestene Chronodose, Diprostene
  • Greece · Celestone Chronodose, Propiochrone
  • Hungary · Diprophos
  • Iceland · Diprospan
  • Luxembourg · Celestone Chronodose, Diprophos Ampoule
  • Netherlands · Celestone Chronodose
  • Norway · Celeston Chronodose
  • Poland · Diprophos
  • Portugal · Diprofos Depot
  • Romania · Diprophos
  • Slovakia · Diprophos

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/79f34dfb-f93d-40b5-851d-20471474b12f
GET /v1/drugs/79f34dfb-f93d-40b5-851d-20471474b12f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL",
    "SmPC"
  ],
  "se_npl_id": "19670122000011",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19670122000011",
  "product_doc_link": "https://docetp.mpa.se/LMF/Celeston%20bifas%20suspension%20for%20injection%20SmPC_09001bee807a1ff4.pdf"
}

See everything about betamethasone acetate + betamethasone sodium phosphate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.